Publicacions destacades

• Differential contribution of elastin and fibrillin-1 to the cardiovascular phenotype of a double heterozygous Marfan and Williams-Beuren syndrome mouse model.

  Rodríguez-Rovira I; Sels L; Ruíz-Castro J; Aizpuru-Gómez A; Dantas AP;

  Campuzano V; Egea G.

  Referència:

  Genes and Diseases 2027.

• Introducing Allopurinol to the Medical Treatment of Marfan Syndrome: Advantages, Limitations, and Potential Extension to other Aortopathies

  Egea, G; de Souza, RB; Teixidó-Turà, G; Mas-Stachurska, A; Evangelista, A;

  Loeys, B.

  Referència:

  CARDIOVASCULAR DRUGS AND THERAPY 2026.

• Dysfunctional Mitochondria in the Cardiac Fibers of a Williams-Beuren Syndrome Mouse Model

  Abdalla, N; Tobías-Baraja, E; Gonzalez, A; Garrabou, G; Egea, G;

  Campuzano, V.

  Referència:

  INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023.

• The Combined Treatment of Curcumin with Verapamil Ameliorates the Cardiovascular Pathology in a Williams–Beuren Syndrome Mouse Model

  Noura Abdalla; Paula Ortiz‐Romero; Isaac Rodríguez-Rovira; Luís A. Pérez-Jurado; Gustavo Egea;

  Victoria Campuzano.

  Referència:

  INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023.

• Allopurinol blocks aortic aneurysm in a mouse model of Marfan syndrome via reducing aortic oxidative stress

  Rodríguez-Rovira I; Arce C; De Rycke K; Pérez B; Carretero A;

  (...)

  Teixidò-Turà G; Gómez-Cabrera MC; Campuzano V; Jiménez-Altayó F; Egea G.

  Veure llistat complet d'autors

  Referència:

  FREE RADICAL BIOLOGY AND MEDICINE 2022.

• Anti-TGFβ (Transforming Growth Factor β) Therapy with Betaglycan-Derived P144 Peptide Gene Delivery Prevents the Formation of Aortic Aneurysm in a Mouse Model of Marfan Syndrome

  Arce, C; Rodríguez-Rovira, I; De Rycke, K; Durán, K; Campuzano, V;

  Fabregat, I; Jiménez-Altayó, F; Berraondo, P; Egea, G.

  Referència:

  ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 2021.

• Co-Treatment With Verapamil and Curcumin Attenuates the Behavioral Alterations Observed in Williams–Beuren Syndrome Mice by Regulation of MAPK Pathway and Microglia Overexpression

  Ortiz-Romero, P; González-Simón, A; Egea, G; Pérez-Jurado, LA; Campuzano, V;

  Referència:

  Frontiers in Pharmacology 2021.

• REDOX STRESS IN MARFAN SYNDROME: DISSECTING THE ROLE OF THE NADPH OXIDASE NOX4 IN AORTIC ANEURYSM.

  Jimenez-Altayo, Francesc; Meirelles, Thayna; Crosas-Molist, Eva; Alba Sorolla, M; Gorbenko del Blanco, Darya;

  (...)

  Laurindo, Francisco; Schroeder, Katrin; Ros, Joaquim; Fabregat, Isabel; Egea, Gustavo.

  Veure llistat complet d'autors

  Referència:

  FREE RADICAL BIOLOGY AND MEDICINE 2018.

• Cardiovascular Benefits of Moderate Exercise Training in Marfan Syndrome: Insights From an Animal Model

  Mas-Stachurska, Aleksandra; Siegert, Anna-Maria; Batlle, Monsterrat; Gorbenko del Blanco, Darya; Meirelles, Thayna;

  (...)

  Baudin, Julio; Sitges, Marta; Mont, Lluis; Guasch, Eduard; Egea, Gustavo.

  Veure llistat complet d'autors

  Referència:

  Journal of the American Heart Association 2017.

• Vascular smooth muscle cell phenotypic changes in patients with marfan syndrome

  Crosas-Molist, Eva; Meirelles, Thayna; Lopez-Luque, Judit; Serra-Peinado, Carla; Selva, Javier;

  (...)

  Sarri, Elisabet; Rodriguez-Pascual, Fernando; Dietz, Harry C; Fabregat, Isabel; Egea, Gustavo.

  Veure llistat complet d'autors

  Referència:

  ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 2015.